ObsEva Announces Update on Board of Directors
2024年3月19日 - 3:00PM
Ad hoc announcement pursuant to Art. 53 LR of the
SIX Swiss Exchange
GENEVA, Switzerland – March 18,
2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical
company developing and commercializing novel therapies for women’s
health, today announced that, concurrent to the decision to
wind-down the company’s operations, Catarina Edfjäll, Ph.D. has
decided to step down from the Board effective today.
“We would like to warmly thank Catarina for her
significant contribution to the company over the last years. We are
grateful to have had the opportunity to work closely with her and
we wish her continued success in her future endeavors,” said Ernest
Loumaye, Board Chairman.
About ObsEva
ObsEva is a biopharmaceutical company developing
novel therapies to improve women’s reproductive health and
pregnancy. ObsEva has established a development program focused on
improving in vitro fertilization success rates. ObsEva is listed on
the SIX Swiss Exchange where it is traded under the ticker symbol
“OBSN”. For more information, please visit www.ObsEva.com.
For further information, please
contact:
For general
information: For
investors information:contact@obseva.ch
IR@obseva.ch
###
- ObsEva - Press Release _Director Departure_ 18.03.2024_Pdf
ObsEva (NASDAQ:OBSV)
過去 株価チャート
から 11 2024 まで 12 2024
ObsEva (NASDAQ:OBSV)
過去 株価チャート
から 12 2023 まで 12 2024